FMR LLC 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Sale | 2025-01-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 2,695,007 2.500% | -8,426,644 (-75.77%) | Filing |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 11,121,651 10.525% | -336,043 (-2.93%) | Filing |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 11,457,694 11.905% | -571,095 (-4.75%) | Filing |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 12,028,789 12.701% | 1,066,820 (+9.73%) | Filing |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 10,961,969 13.456% | -1,061,615 (-8.83%) | Filing |